June 26 (Reuters) - Nexalin Technology Inc NXL.O :
* NEXALIN TECHNOLOGY ANNOUNCES POSITIVE CLINICAL STUDY DATA
IN
MAJOR DEPRESSIVE DISORDER AND PUBLICATION OF CLINICAL TRIAL
RESULTS IN LEADING SCIENTIFIC JOURNAL
* NEXALIN TECHNOLOGY: STUDY SHOWS STRONG STATISTICAL
SEPARATION
BETWEEN PATIENTS RECEIVING NEXALIN'S DIFS TECHNOLOGY WITH
ESCITALOPRAM VERSUS SHAM GROUP
* NEXALIN TECHNOLOGY INC - NO SERIOUS ADVERSE EVENTS
OBSERVED IN
TRIAL
Source text for Eikon: ID:nGNX6tJyG3
Further company coverage: NXL.O
((Reuters.Briefs@thomsonreuters.com;))